• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CSL 0.10% $277.63

CSL LIMITED

Montu is a fully licensed medical cannabis company with a clear focus on the Australian... Montu is a fully licensed medical cannabis company with a clear focus on the Australian and New Zealand market. While the company offers its own medicinal-grade cannabis and cannabis-based medicines under the Circle brand, Montu's primary focus is making it easier for patients to access these crucial treatments.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CSL 21/05/24 8 4.2K
21/05/24 Last post  Burgerbuns Comments Created with Sketch.  8  Views Created with Sketch.  4.2K 
CSL
News: CSL Banks push Australia shares down; James Hardie dips to 5-month low
21/05/24 0 134
21/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  134 
CSL
Arct-154
21/05/24 1 279
TRENDING NEWS

Unlock the secrets of ASX healthcare investments - join industry leaders & innovators today!

NEWS
21 May 2024
21/05/24 Last post  W534220 Comments Created with Sketch.  1  Views Created with Sketch.  279 
CSL
CSL - $300 and beyond
2
21/05/24 77 38K
21/05/24 Last post  mybestaccount Comments Created with Sketch.  77  Views Created with Sketch.  38K 
CSL
News: CSL Australian shares gain on miners boost; US CPI on tap
15/05/24 0 239
15/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  239 
CSL
Garadacimab for HAE long term results “complete disease control”
15/05/24 1 427
15/05/24 Last post  W534220 Comments Created with Sketch.  1  Views Created with Sketch.  427 
CSL
News: CSL Australia's CSL tests 'dynamic pricing' of donor blood amid cost surge
07/05/24 1 795
07/05/24 Last post  W534220 Comments Created with Sketch.  1  Views Created with Sketch.  795 
CSL
European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
03/05/24 0 352
03/05/24 Last post  W534220 Comments Created with Sketch.  0  Views Created with Sketch.  352 

See All Discussions arrow Created with Sketch.

Timeline

Notification of cessation of securities - CSL
03 May 12:12
 
Shareholder Information Meetings
23 Apr 09:58
 
CSL Australia Investor Site Tour Presentations
11 Apr 08:25
 
Publication of AEGIS II Trial Data
08 Apr 08:33
 
Notification of cessation of securities - CSL
05 Apr 15:20
 
CSL prices US$1.25 billion in Corporate Bonds
27 Mar 08:31
 
View More arrow Created with Sketch.
(20min delay)
Last
$277.63
Change
-0.270(0.10%)
Mkt cap ! $134.1B
Open High Low Value Volume
$277.94 $279.11 $276.35 $217.1M 783.0K

Buyers (Bids)

No. Vol. Price($)
1 315 $277.61
 

Sellers (Offers)

Price($) Vol. No.
$277.63 49 1
View Market Depth
Last trade - 16.10pm 21/05/2024 (20 minute delay) ?
Last
$277.63
  Change
-0.270 ( 0.34 %)
Open High Low Volume
$278.97 $278.97 $276.36 25608
Last updated 16.10pm 21/05/2024 ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.